Medpace Holdings, Inc.
MEDP
株式のランク
#1241
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
株価
$658.55
時価総額
$18.38B
変化（1日）
5.80%
変化（1年）
20.69%
国
US
取引 Medpace Holdings, Inc. (MEDP)
カテゴリー
Healthcare
Medpace Holdings, Inc.（MEDP）の収益
Jun 2026 時点の収益 TTM: $2.78B
Medpace Holdings, Inc. の最新の財務報告によると、現在の収益 (TTM) は $2.78B です。2024 年には $2.11B の収益があり、これは 2023 年の $1.89B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Medpace Holdings, Inc. の収益履歴（2013 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $2.78B | 9.96% |
| 2025 | $2.53B | 19.97% |
| 2024 | $2.11B | 11.84% |
| 2023 | $1.89B | 29.17% |
| 2022 | $1.46B | 27.80% |
| 2021 | $1.14B | 23.38% |
| 2020 | $925.93M | 7.54% |
| 2019 | $860.97M | 22.19% |
| 2018 | $704.59M | 61.55% |
| 2017 | $436.15M | 3.46% |
| 2016 | $421.58M | 17.41% |
| 2015 | $359.06M | 23.80% |
| 2014 | $290.04M | 6.28% |
| 2013 | $272.89M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 1,565.39% |
US
|
|
| $25.11B | 802.39% |
US
|
|
| $2.71B | -2.70% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 164.96% |
US
|
